MedicalResearch.com Interview with:
Anna Gundlund, MD, PhD
Herlev-Gentofte Hospital, Department of Cardiology
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Atrial fibrillation increases a person’s risk of ischemic strokes up to 5-fold. Oral anticoagulation therapy lowers this risk effectively (>60%) and is therefore recommended for patients with atrial fibrillation and at least 1-2 other risk factors for stroke.
Our study show, that oral anticoagulation therapy is still underused in patients with atrial fibrillation – even after a stroke event. In stroke survivors with atrial fibrillation, oral anticoagulation therapy were associated with better outcomes than no oral anticoagulation therapy. Continue reading